Caldesmon’s decreased expression has been identified in gastric cancer lymph node metastatic cells using a proteomics approach and loss of caldesmon expression could be associated with gastric cancer metastasis progression (Hou et al., 2013). Here, CALD1 is linked to gastric cancer.